Z
Power Law company profile
Zai Lab
Biotech & Life Sciences · Pudong, China · Founded 2014 · IPO 2017 Unicorn
Valuation
$1.99B
Market cap · Apr/2026
Revenue
$460M
Latest reported FY
Global footprint
Where Zai Lab has talent and traffic
Web traffic by country
22K
monthly visits
across markets
across markets
🇺🇸 United States40.9%
🇨🇦 Canada11.8%
🇬🇧 United Kingdom9.1%
🇸🇬 Singapore8.2%
🇭🇰 Hong Kong8.2%
Patent intelligence
$12M patent portfolio · 16 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$12M
0.62% of market cap · 26.6× smaller than top peer Genmab ($328M)
16 active patent families
Where Zai Lab innovates
Antiendomysial antibodiesCancer researchMolecular biologyCarcinosisPharmacology
Below peer median on Strategic
Quality vs same-sector peers
Zai Lab on the five Patsnap quality dimensions
Zai Lab in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Zai Lab concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Zai Lab and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Zai Lab on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.